Influence of gestation, regular bleeding and intermittent exposure on blood perfluorooctane sulfonate levels in mice: potential factors inducing sex difference and affecting exposure evaluation.
Higher blood levels of perfluorooctane sulfonate (PFOS) in males than the females have been observed in many human biomonitoring studies, which is not well explained yet. The effects of gestation and regular bleeding on blood PFOS level in mice were investigated to evaluate the potential factors that could result in the sex difference. The mice were exposed to PFOS via drinking water at a concentration of 50 mug/l. After 6 weeks of pre-exposure and the gestation period, the blood PFOS concentrations in the gestagenic mice were significantly lower than the control non-gestagenic mice with a ratio of 0.45. Significant lower blood PFOS concentrations in the male mice treated by regular artificial bleeding were observed compared with those from the control male. However, such difference was not observed for the females. The sex difference in the effect of regular artificial bleeding on the blood PFOS level may be caused by the different accumulation and elimination rate in the female and male mice. In addition, the effect of intermittent exposure to PFOS on blood level was evaluated. Each single exposure caused a significant increase in blood PFOS level in both females and males, suggesting the acute exposure to PFOS occurred before the blood sampling, e.g. exposure to PFOS-contaminated foods or drinks, would affect the biomonitoring data to some extent depending on the background blood level. Thus serial blood monitoring is required to obtain accurate body burden.
Liu
Wei
W
School of Environmental and Biological Science and Technology, Dalian University of Technology, Key Laboratory of Industrial Ecology and Environmental Engineering, Dalian, China.
Li
Xiao
X
Xu
Lei
L
Liu
Li
L
Jin
Yihe
Y
Sato
Itaru
I
Tsuda
Shuji
S
D017738:Alkanesulfonic Acids / Q000008:administration & dosage / Q000097:blood* / Q000378:metabolism / Q000633:toxicity*; D000818:Animals; D001822:Body Burden; D030762:Estrous Cycle / Q000502:physiology*; D005260:Female; D005466:Fluorocarbons / Q000008:administration & dosage / Q000097:blood* / Q000378:metabolism / Q000633:toxicity*; D006470:Hemorrhage; D006801:Humans; D008297:Male; D018811:Maternal Exposure; D008431:Maternal-Fetal Exchange; D051379:Mice; D011247:Pregnancy / Q000502:physiology*; D012727:Sex Characteristics; D013501:Surface-Active Agents / Q000008:administration & dosage / Q000633:toxicity*
D017738:Alkanesulfonic Acids; D005466:Fluorocarbons; D013501:Surface-Active Agents; C076994:perfluorooctane sulfonic acid